Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Premier Laser Systems

This article was originally published in The Gray Sheet

Executive Summary

Irvine, California-based laser firm going public in an initial offering of 3 mil. units at a price of $3.50 per unit, according to a registration statement filed with the Securities and Exchange Commission. The units are comprised of one share Class A common stock, one Class A warrant, and one Class B warrant. The offering is being underwritten by D. H. Blair Banking Corp., which receives an over-allotment option to purchase up to 450,000 additional units at the public offering price. Premier plans to use $4.3 mil. of the proceeds from the offering to pay off bridge notes, "other liabilities," and notes pertaining to the management buyout of Pfizer Laser Systems in 1991, which led to the creation of Premier ("The Gray Sheet" Jan. 24, I&W-2). Remaining proceeds are allocated to the expansion of marketing and distribution capability and working capital.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT002926

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel